HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dc06-2422v1 30/9/2193    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, S. B. Search for Related Content PubMed PubMed Citation Articles by Johnson, S. B. Social Bookmarking                What's this?

Participant and Parent Experiences in the Parenteral Insulin Arm of the Diabetes Prevention Trial for Type 1 Diabetes

¹ Department of Medical Humanities and Social Sciences, Florida State College of Medicine, Tallahassee, Florida
² Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts
³ Diabetes Research Institute, University of Miami Medical School, Miami, Florida
⁴ Department of Pediatrics, College of Medicine, University of Florida, Gainesville, Florida

Address correspondence and reprint requests to Suzanne Bennett Johnson, PhD, Department of Medical Humanities and Social Sciences, 1115 West Call St., Tallahassee, FL 32306-4300. E-mail: suzanne.johnson{at}med.fsu.edu

OBJECTIVE—To assess participant and parent experiences in the parenteral insulin arm of the Diabetes Prevention Trial for Type 1 Diabetes (DPT-1).

RESEARCH DESIGN AND METHODS—Before trial results were publicized, surveys were completed by 82 intervention participants (the intervention group) (who received annual 4-day insulin infusions and daily insulin injections), 81 closely monitored control subjects (the closely monitored group), and 135 parents of children in the trial.

RESULTS—Survey results suggest that participant perspective (adult, child, parent, and sex), study procedures, and group assignment have important implications when planning clinical trials. Parents rated the trial more favorably but worried about hypoglycemia and diabetes onset. Children had the least favorable reaction to the study. Parents preferred assignment to the intervention group; child/adult participants preferred assignment to the closely monitored group. The intervention group rated the annual 4-day insulin infusions more negatively than all other study procedures. Intervention group participants/parents reported poorer insulin injection adherence over the course of the study. Intervention group participants, parents, and female subjects expressed an interest in additional psychosocial support during the trial. Random assignment was viewed negatively by both study groups. Close observation for diabetes onset was viewed as the most favorable aspect of the study. Behaviors outside of the study protocol to prevent or delay diabetes onset were common and should be monitored in future prevention studies.

CONCLUSIONS—Overall, most participants were positive about the trial, and many expressed optimism about the intervention's potential for success. These results have implications for study design, recruitment, and retention procedures in future prevention trials.

Abbreviations: DPT-1, Diabetes Prevention Trial for Type 1 Diabetes • OGTT, oral glucose tolerance test

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Sosenko, J. P. Palmer, L. Rafkin-Mervis, J. P. Krischer, D. Cuthbertson, D. Matheson, and J. S. Skyler Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 Diabetes Care, November 1, 2008; 31(11): 2188 - 2192. [Abstract] [Full Text] [PDF]